If you’re aiming for more senior roles or specialized positions, the questions get pretty intense. They’ll be testing your ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results